The Janssen Pharmaceutical Companies of Johnson & Johnson’s Post

Alzheimer’s disease is a degenerative, progressive brain disease accounting for 60-80% of demetia cases, and with each diagnosis comes much uncertainty for both the patient and their loved ones. Read the article below to learn from patients and caregivers about common misconceptions associated with this disease, and how we can better understand the experience of those living with it.   #WorldAlzDay #WorldAlzMonth #ENDALZ #AlzheimersDisease

To view or add a comment, sign in

Explore topics